Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial-Reference-Cited by-同舟云学术

Three months of combination therapy with nano‐curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double‐blinded, placebo‐controlled clinical trial

Published:2022-06-08 Issue:1 Volume:49 Page:108-118
ISSN:0951-6433
Container-title:BioFactors
language:en
Short-container-title:BioFactors

Author:

Dastani Mostafa¹,Rahimi Hamid Reza²³,Askari Vahid Reza⁴⁵⁶,Jaafari Mahmoud Reza⁷,Jarahi Lida⁸,Yadollahi Asal¹,Rahimi Vafa Baradaran¹^ORCID

Affiliation:

1. Department of Cardiovascular Diseases, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran

2. Vascular and Endovascular Surgery Research Center Mashhad University of Medical Sciences Mashhad Iran

3. Department of Medical Genetics and Molecular Medicine School of Medicine, Mashhad University of Medical Sciences Mashhad Iran

4. Applied Biomedical Research Center Mashhad University of Medical Sciences Mashhad Iran

5. Department of Pharmaceutical Sciences in Persian Medicine School of Persian and Complementary Medicine, Mashhad University of Medical Sciences Mashhad Iran

6. Department of Persian Medicine School of Persian and Complementary Medicine, Mashhad University of Medical Sciences Mashhad Iran

7. Nanotechnology Research Center Pharmaceutical Technology Institute, Mashhad University of Medical Sciences Mashhad Iran

8. Department of Community Medicine, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran

Funder

Mashhad University of Medical Sciences

Publisher

Wiley

Subject

Clinical Biochemistry,Molecular Medicine,General Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/biof.1874

Reference35 articles.